PP

PagodaTree Partners

Asia, Beijing, China, Beijing

Description

PagodaTree Partners is an investment firm.

Investor Profile

PagodaTree Partners has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does PagodaTree Partners frequently co-invest with?

Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 1
BS
North America, Massachusetts, United States, Boston
Co-Investments: 1
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
Sixty Degree Capital
North America, Ontario, Canada, Toronto
Co-Investments: 1
Leaps by Bayer
Europe, Nordrhein-Westfalen, Germany, Leverkusen
Co-Investments: 1
Sanofi Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 1

Which angels does PagodaTree Partners often collaborate with?

GF
North America, California, United States
Shared Deals: 1

What are some of recent deals done by PagodaTree Partners?

NextPoint Therapeutics

Cambridge, Massachusetts, United States

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

BiotechnologyHealth CareLife ScienceTherapeutics
Series BJan 10, 2023
Amount Raised: $80,000,000